27/10/23 | 8:45 am

Print

CCI Approves Renault and Nissan cross-shareholding rebalancing

The Competition Commission of India (CCI) has granted approval for a proposed combination involving the re-balancing of cross-shareholdings between two automotive giants, Renault and Nissan. This move has far-reaching implications for their joint ventures in India, marking a crucial step in their strategic realignment.

The proposed combination primarily centers on the re-balancing of existing cross-shareholdings between Renault S.A. (Renault) and Nissan Motor Co. Ltd. (Nissan), as well as certain changes to the shareholding structures of their joint ventures in India, specifically Renault Nissan Automotive India Private Limited (RNAIPL) and Renault Nissan Technology & Business Centre India Private Limited (RNTBCI).

As part of this re-balancing effort, Nissan, represented by Nissan Finance Co. Ltd. (NFC), will retain a 15% shareholding in Renault. Meanwhile, Renault will transfer 28.4% of its Nissan shares into a trust estate administered by a trustee governed by French law. The entrusted shares in this trust will be voted neutrally, with limited exceptions. Renault will continue to enjoy the economic rights associated with these entrusted shares until they are eventually sold. This strategic maneuver will result in Renault and Nissan each holding a 15% share in one another and possessing freely exercisable voting rights.

Nissan's presence in India is channeled through its affiliate entities engaged in the sale of passenger vehicles and automotive parts, primarily through its wholly-owned subsidiary, Nissan Motor India Private Limited (NMIPL). Under the Nissan brand, NMIPL offers a range of passenger vehicles in the Indian market.

On the other hand, Renault and its affiliated entities in India operate through Renault India Private Limited (RIPL), their wholly-owned subsidiary. RIPL is responsible for the sale of automobiles and parts, offering passenger and utility vehicles under the 'Renault' brand in India.

RNAIPL, another crucial entity in this combination, is currently involved in the manufacturing and assembly of passenger vehicles. It handles transmissions, components, vehicle parts, and provides related services exclusively to Renault and Nissan.

RNTBCI plays a pivotal role in the ecosystem as a captive automotive technology and business center that supports Renault and Nissan in various aspects of their operations, including research and development, engineering, manufacturing, technology, product planning, process, and information technology.

The CCI's approval of this strategic combination demonstrates the regulator's support for the re-balancing efforts between Renault and Nissan, fostering a more equitable partnership and setting the stage for potentially new and innovative developments in the Indian automotive industry. This move is expected to have a positive impact on the collaboration between these two automotive giants and their operations in India, further strengthening their foothold in the country's competitive automotive market.

RELATED ARTICLES

09/06/26 | 4:16 pm | Indian equity markets

Nifty, Sensex end higher on fag-end buying; PSU banks and financial stocks lead rally

Indian equity markets ended higher on Tuesday, supported by late buying in select sectors such as PSU banks, financial services, and automobiles, while improving global risk sentiment also aided investor confidence. The benchmark indices closed in t...

09/06/26 | 3:04 pm | Mihir Kumar

GeM Procurement from MSEs Crosses Rs 8.69 Lakh Crore; Registered Units Rise to 11.9 Lakh

The Government e Marketplace (GeM) has recorded procurement worth more than ₹8.69 lakh crore from micro and small enterprises (MSEs), while the number of registered MSEs on the platform has increased to over 11.9 lakh from 2,396 in 2016-17, accordi...

09/06/26 | 10:55 am | GDRC (Global Drug Regulators Conclave) 2026

Piyush Goyal invites global pharma firms to invest in India

Union Commerce and Industry Minister Piyush Goyal on Monday invited global pharmaceutical companies to partner with India as it advances towards innovation-led and inclusive healthcare, saying the country's pharmaceutical industry, currently valued a...